Table 3. Overview of complications within the 12-month study period (independent ESD phase).
1st study period | 2nd study period | Total | |
Major complications | |||
|
0 | 1 | 1 |
|
1 | 0 | 1 |
|
1 (7 %) | 1 (7 %) | 2 (7 %) |
1st study period | 2nd study period | Total | |
Major complications | |||
|
0 | 1 | 1 |
|
1 | 0 | 1 |
|
1 (7 %) | 1 (7 %) | 2 (7 %) |